论文信息 - Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial - 字舞流文

Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial

R. Motzer | B. Escudier | A. Shah | C. Scheffold | T. Choueiri | M. Bourlon | M. Richardet | V. Fedorov | C. Porta | Y. Tomita | C. Barrios | T. Powles | A. Apolo | S. George | M. Burotto | C. Suárez | H. Gurney | E. R. Kessler | J. Bedke | P. Wang | Prof. Thomas Powles